Nonabsorbable Bone Staple Market Size, Share, Growth, and Industry Analysis, By Type (Pediatrics, Aldult), By Application (Foot Surgery, Vertebrae Surgery, Other), Regional Insights and Forecast to 2035

Nonabsorbable Bone Staple Market Overview

The global Nonabsorbable Bone Staple Market size estimated at USD 307.74 million in 2026 and is projected to reach USD 519.5 million by 2035, growing at a CAGR of 6% from 2026 to 2035.

The nonabsorbable bone staple market expanded steadily in 2025 due to increasing orthopedic surgeries and rising demand for stable bone fixation devices. More than 8.7 million orthopedic fixation procedures were performed globally during 2025, while nonabsorbable bone staples represented 18% of internal fixation device usage in foot and small bone surgeries. Titanium-based bone staples accounted for 63% of product demand because of high biocompatibility and corrosion resistance. Shape-memory compression staples improved fixation stability by 27% in reconstructive procedures. Hospitals represented 71% of total end-user demand globally. North America contributed 39% of market consumption because of advanced orthopedic surgical infrastructure and increasing sports injury treatments.

The United States nonabsorbable bone staple market accounted for approximately 34% of global demand in 2025 due to high orthopedic procedure volumes and strong adoption of minimally invasive surgical technologies. More than 1.2 million foot and ankle surgeries were performed annually across the United States, while compression bone staples were used in 29% of these procedures. Titanium staples represented 68% of national product utilization because of superior mechanical strength and MRI compatibility. Ambulatory surgical centers contributed 22% of U.S. product demand during 2025. Sports-related fracture treatments increased by 19%, while shape-memory staple adoption rose by 24% in reconstructive orthopedic surgeries nationwide.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Orthopedic surgical procedures increased by 23%, sports injury treatments expanded by 19%, minimally invasive fixation surgeries rose by 28%, and titanium compression staple adoption improved by 26% globally during 2025.
• Major Market Restraint: High implant costs affected 21% of healthcare facilities, post-surgical complication concerns influenced 17% of surgeons, reimbursement limitations reduced adoption by 14%, and product recall incidents impacted 11% of orthopedic fixation procedures.
• Emerging Trends: Shape-memory alloy staples adoption increased by 29%, minimally invasive orthopedic fixation procedures rose by 31%, MRI-compatible implant demand improved by 22%, and patient-specific implant customization expanded by 18% globally.
• Regional Leadership: North America accounted for 39% of nonabsorbable bone staple demand, Europe represented 31%, Asia-Pacific held 23%, while Middle East and Africa contributed 7% through orthopedic care modernization initiatives.
• Competitive Landscape: The top five manufacturers controlled 57% of orthopedic staple production, while titanium implant utilization increased by 33% and hospital-based orthopedic fixation procedures expanded by 24% globally during 2025.
• Market Segmentation: Adult procedures represented 81% of nonabsorbable bone staple demand, pediatric applications accounted for 19%, foot surgery contributed 54% of procedures, vertebrae surgery represented 28%, and other applications held 18%.
• Recent Development: Nitinol compression staple adoption increased by 27%, bioengineered fixation coating integration rose by 19%, low-profile staple systems expanded by 23%, and robotic-assisted orthopedic implantation procedures improved by 16% during 2025.

Nonabsorbable Bone Staple Market Latest Trends

The nonabsorbable bone staple market witnessed major advancements in 2025 due to rising orthopedic surgical demand and innovations in fixation technologies. Shape-memory nitinol staples represented 36% of newly introduced orthopedic staple systems because they improved dynamic compression and accelerated bone healing stability by 27%. Titanium staples accounted for 63% of overall market demand because of strong biocompatibility and MRI compatibility.

Minimally invasive orthopedic surgeries increased by 31%, encouraging the use of low-profile nonabsorbable bone staples with reduced soft tissue disruption. Hospitals adopted robotic-assisted implantation systems in 18% of complex orthopedic procedures during 2025. Customized orthopedic fixation devices manufactured through 3D printing technologies expanded by 21%. Foot and ankle surgeries represented 54% of total nonabsorbable bone staple utilization because bunion correction and fusion procedures increased significantly worldwide. Outpatient orthopedic surgical centers accounted for 22% of product demand due to shorter recovery times and reduced hospitalization requirements. Asia-Pacific manufacturers improved nitinol staple fatigue resistance by 19%, increasing implant durability. Bioactive surface coatings enhancing osseointegration expanded by 17%, while antimicrobial-coated orthopedic staples reduced post-operative infection risks by 14% during 2025.

Nonabsorbable Bone Staple Market Dynamics

DRIVER

"Rising orthopedic surgeries and sports injury treatments worldwide."

The increasing number of orthopedic surgical procedures significantly boosted demand for nonabsorbable bone staples during 2025. More than 8.7 million orthopedic fixation surgeries were performed globally, with foot and ankle procedures accounting for 32% of cases. Sports injuries increased by 19%, particularly among athletes aged 18 to 39 years, driving higher adoption of stable bone fixation devices. Minimally invasive surgical techniques improved patient recovery times by 24%, encouraging wider utilization of low-profile orthopedic staples. Titanium and nitinol staples reduced implant failure rates by 16% compared to traditional fixation devices. Hospitals represented 71% of total product demand because advanced orthopedic operating infrastructure supported complex reconstructive procedures. Aging populations contributed significantly to orthopedic surgery volumes, with adults above 60 years accounting for 38% of fixation-related procedures globally. Shape-memory compression staples improved bone fusion outcomes by 27% in small bone surgeries, further strengthening market growth.

RESTRAINT

"High procedural costs and post-surgical complication concerns."

The high cost of advanced orthopedic fixation systems limited product adoption across smaller healthcare facilities during 2025. Titanium-based compression staples remained 29% more expensive than traditional fixation screws and wires. Reimbursement limitations affected 14% of orthopedic centers, particularly in developing healthcare systems. Post-surgical complications such as implant migration and soft tissue irritation impacted approximately 11% of orthopedic fixation procedures. Surgeons required specialized training for advanced staple implantation systems, increasing procedural preparation time by 17%. Regulatory approval timelines for innovative orthopedic implants exceeded 18 months in several developed healthcare markets. Product recalls related to mechanical fatigue issues affected 9% of orthopedic implant batches between 2023 and 2025. Sterilization and inventory management costs increased by 13% for hospitals using multiple orthopedic fixation systems. Patients with metal sensitivity concerns represented 8% of orthopedic implant candidates, limiting adoption of certain nonabsorbable metallic staples.

OPPORTUNITY

"Growth in minimally invasive and patient-specific orthopedic fixation technologies."

The rapid expansion of minimally invasive orthopedic surgery created strong opportunities for nonabsorbable bone staple manufacturers during 2025. Robotic-assisted orthopedic procedures increased by 16%, improving implant positioning precision and surgical efficiency. Patient-specific fixation implants developed through 3D printing technologies expanded by 21%, particularly in reconstructive foot and vertebral surgeries. Nitinol shape-memory staples improved dynamic compression performance by 27%, increasing adoption in complex fusion procedures. Outpatient orthopedic surgery centers represented 22% of market demand because shorter recovery periods reduced hospital admissions. Antimicrobial-coated orthopedic staples reduced infection risks by 14%, encouraging adoption in trauma surgeries. Asia-Pacific healthcare infrastructure modernization projects increased orthopedic surgical capacity by 24%. Pediatric orthopedic procedures represented 19% of market demand, creating opportunities for smaller and low-profile fixation systems. Hospitals integrating AI-assisted surgical planning software improved orthopedic implant accuracy by 18%. MRI-compatible orthopedic implants expanded by 22%, supporting patients requiring long-term imaging diagnostics after surgery.

CHALLENGE

"Regulatory compliance and long-term implant durability concerns."

Regulatory compliance requirements for orthopedic implants increased manufacturing costs by 15% during 2025. Nonabsorbable bone staples required extensive biomechanical testing before approval, delaying product launches by an average of 14 months. Long-term implant fatigue concerns affected 12% of surgeons selecting fixation systems for weight-bearing procedures. Complex revision surgeries associated with failed orthopedic implants increased healthcare costs by 18%. Metal ion release concerns influenced 9% of patient treatment decisions involving metallic fixation devices. Sterilization standards for orthopedic implants became stricter across Europe and North America, increasing quality assurance expenses by 11%. Hospitals faced inventory management challenges because orthopedic procedures required more than 40 staple size variations for different bone structures. Supply chain disruptions affecting titanium and nitinol materials increased manufacturing delays by 13% globally. Surgeon preference for traditional screw fixation systems limited staple adoption in 16% of orthopedic procedures despite improved compression technology advancements.

Nonabsorbable Bone Staple Market Segmentation

Download Free Sample to learn more about this report.

The nonabsorbable bone staple market is segmented by type and application, with adult orthopedic procedures accounting for 81% of total product demand in 2025 because aging populations and sports injuries increased fixation surgery volumes. Pediatric applications represented 19% due to congenital deformity correction and trauma procedures. Foot surgery dominated with 54% market share because bunion correction and arthrodesis procedures relied heavily on compression staple fixation systems. Vertebrae surgery accounted for 28% due to spinal fusion procedure growth. Titanium staples represented 63% of overall demand globally, while nitinol shape-memory staples contributed 36% of newly introduced orthopedic fixation systems during 2025.

BY TYPE

Pediatrics: Pediatric applications accounted for 19% of the nonabsorbable bone staple market in 2025 because congenital deformity corrections and pediatric trauma surgeries increased globally. More than 1.4 million pediatric orthopedic procedures were performed annually worldwide, with foot deformity correction representing 31% of cases. Low-profile nonabsorbable bone staples improved fixation stability while minimizing growth plate disruption in children. Titanium staples represented 58% of pediatric orthopedic fixation demand because of high biocompatibility and lower allergic reaction risks. Shape-memory nitinol staples improved fusion compression efficiency by 23% in pediatric reconstructive procedures. Hospitals specializing in pediatric orthopedics accounted for 64% of product utilization. Minimally invasive pediatric surgeries increased by 21%, encouraging the adoption of smaller orthopedic staple systems. North America represented 37% of pediatric nonabsorbable bone staple demand due to advanced children’s orthopedic care infrastructure and rising sports-related injury treatments among adolescents.

Adult: Adult procedures dominated the nonabsorbable bone staple market with 81% share in 2025 because aging populations and sports injury treatments increased orthopedic surgical volumes globally. More than 7.1 million adult orthopedic fixation surgeries involved nonabsorbable implants during 2025. Foot and ankle reconstruction procedures represented 39% of adult fixation demand due to increasing osteoarthritis and trauma-related surgeries. Titanium staples accounted for 66% of adult orthopedic staple utilization because of superior strength and MRI compatibility. Shape-memory nitinol staples improved fusion success rates by 27% in arthrodesis procedures. Adults above 60 years represented 38% of orthopedic staple recipients globally because degenerative bone disorders increased significantly.

BY APPLICATION

Foot Surgery: Foot surgery dominated the nonabsorbable bone staple market with 54% share in 2025 because bunion correction, osteotomy, and arthrodesis procedures increasingly utilized compression staple systems. More than 3.8 million foot surgeries involving fixation implants were performed globally during 2025. Nitinol compression staples improved bone fusion stability by 27% in first metatarsophalangeal joint procedures. Titanium staples accounted for 61% of foot surgery fixation systems because of strong corrosion resistance and long-term implant durability. Minimally invasive foot surgery techniques increased by 29%, encouraging the adoption of low-profile staple systems. Outpatient surgical centers represented 31% of foot surgery fixation demand due to shorter patient recovery periods. North America accounted for 41% of foot surgery staple utilization globally because sports injuries and degenerative foot conditions remained highly prevalent. Shape-memory staples reduced procedure time by 18% compared to conventional fixation techniques.

Vertebrae Surgery: Vertebrae surgery represented 28% of the nonabsorbable bone staple market in 2025 due to rising spinal fusion procedures and increasing degenerative disc disorder treatments. More than 2.1 million spinal fixation surgeries were performed globally during 2025. Nitinol compression staples improved vertebral fusion compression efficiency by 24% in cervical and lumbar fixation procedures. Hospitals accounted for 79% of vertebrae surgery product demand because advanced imaging and robotic surgical systems supported complex spinal operations. Titanium spinal staples represented 67% of vertebrae fixation usage due to MRI compatibility and long-term structural stability. Adults above 55 years accounted for 44% of vertebral fixation procedures because degenerative spinal conditions increased significantly. Robotic-assisted spinal surgeries improved staple placement precision by 19% during 2025. Europe and North America together represented 72% of vertebrae surgery staple demand due to advanced orthopedic and neurosurgical infrastructure.

Other: Other applications accounted for 18% of the nonabsorbable bone staple market in 2025 and included hand surgery, trauma fixation, craniofacial reconstruction, and orthopedic oncology procedures. More than 1.5 million orthopedic procedures globally utilized nonabsorbable bone staples outside foot and vertebral applications. Hand surgery represented 34% of these procedures because compression staples improved fixation stability in small bone fractures. Titanium staples accounted for 62% of other orthopedic applications because of high fatigue resistance and biocompatibility. Trauma-related surgeries increased by 17% during 2025 due to rising road accident injuries and sports fractures. Pediatric reconstructive procedures represented 12% of other application demand globally. Hospitals using robotic-assisted orthopedic systems improved implant positioning precision by 16%. Asia-Pacific accounted for 24% of other application procedures because healthcare modernization increased orthopedic surgical capacity significantly during 2025.

Nonabsorbable Bone Staple Market Regional Outlook

Download Free Sample to learn more about this report.

The nonabsorbable bone staple market displayed strong regional diversification in 2025, with North America leading global demand at 39% due to advanced orthopedic surgery infrastructure and high sports injury treatment rates. Europe represented 31% because of increasing minimally invasive fixation procedures and aging populations. Asia-Pacific accounted for 23% due to healthcare modernization and rising orthopedic surgery volumes. Middle East and Africa contributed 7% through expanding trauma care and orthopedic reconstruction services. Titanium staples represented 63% of regional product demand globally. Hospitals accounted for 71% of nonabsorbable bone staple utilization worldwide because advanced surgical centers supported complex fixation procedures and robotic-assisted orthopedic operations.

NORTH AMERICA

North America dominated the nonabsorbable bone staple market with 39% share in 2025 due to increasing orthopedic surgical procedures and widespread adoption of minimally invasive fixation technologies. The United States represented 84% of regional product demand, while Canada contributed 11%. More than 2.9 million orthopedic fixation surgeries were performed annually across North America using nonabsorbable implants. Foot and ankle surgeries represented 43% of regional nonabsorbable bone staple utilization because bunion correction and sports injury treatments remained highly prevalent. Titanium staples accounted for 68% of product demand due to high biocompatibility and MRI compatibility. Shape-memory nitinol staples improved fusion compression performance by 27% in orthopedic reconstructive procedures. Hospitals represented 73% of regional demand because advanced orthopedic operating infrastructure supported robotic-assisted surgeries. Outpatient orthopedic surgical centers accounted for 24% of fixation procedures due to shorter recovery periods and reduced hospitalization costs. Sports injuries increased by 19% across North America during 2025, strengthening demand for compression fixation systems. Robotic-assisted orthopedic procedures improved implant positioning precision by 18%. North America also led innovation in antimicrobial-coated orthopedic staples, reducing post-operative infection risks by 14%.

EUROPE

Europe accounted for 31% of the nonabsorbable bone staple market in 2025 because aging populations and advanced orthopedic healthcare systems increased surgical fixation demand. Germany, France, the United Kingdom, and Italy together represented 69% of regional product utilization. More than 2.4 million orthopedic fixation procedures involving nonabsorbable implants were performed across Europe during 2025. Minimally invasive orthopedic surgeries increased by 29%, encouraging the use of low-profile compression staple systems. Titanium staples represented 64% of European product demand due to strong corrosion resistance and long-term durability. Shape-memory nitinol staples improved fusion stability by 26% in foot reconstruction surgeries. Hospitals accounted for 71% of regional orthopedic staple utilization, while outpatient surgical centers contributed 21%. Adults above 60 years represented 41% of fixation-related procedures because degenerative orthopedic disorders increased significantly. Europe also demonstrated strong adoption of MRI-compatible orthopedic implants, which expanded by 22% during 2025. Robotic-assisted spinal surgeries improved vertebral staple placement precision by 17%. Bioactive coating integration improving osseointegration increased by 16% in European orthopedic fixation products.

ASIA-PACIFIC

Asia-Pacific represented 23% of the nonabsorbable bone staple market in 2025 due to healthcare infrastructure modernization and rising orthopedic trauma treatments. China, Japan, India, and South Korea together accounted for 74% of regional product demand. More than 2.1 million orthopedic fixation procedures involving nonabsorbable implants were performed annually across Asia-Pacific. Titanium staples accounted for 59% of regional demand because hospitals prioritized durable and cost-efficient fixation systems. Sports injuries increased by 18% during 2025, strengthening demand for orthopedic reconstruction implants. Minimally invasive orthopedic surgeries improved by 27%, particularly in urban healthcare centers. Hospitals represented 76% of regional product utilization because large public healthcare systems handled complex trauma surgeries. Pediatric orthopedic procedures accounted for 21% of regional fixation demand due to increasing congenital deformity treatments. Asia-Pacific manufacturers improved nitinol fatigue resistance by 19%, increasing implant longevity and compression stability. Outpatient orthopedic surgical centers expanded by 17%, supporting faster recovery-focused treatment protocols. Government healthcare modernization projects increased orthopedic surgical capacity by 24% across major Asia-Pacific economies during 2025.

MIDDLE EAST & AFRICA

Middle East and Africa accounted for 7% of the nonabsorbable bone staple market in 2025 due to expanding orthopedic trauma care and rising reconstructive surgery demand. Saudi Arabia, the United Arab Emirates, and South Africa together represented 58% of regional product utilization. More than 610,000 orthopedic fixation surgeries involving nonabsorbable implants were performed across the region during 2025. Trauma surgeries accounted for 36% of regional orthopedic staple demand because road accident injuries remained highly prevalent. Titanium staples represented 61% of product utilization due to strong durability and reduced complication risks. Hospitals accounted for 79% of orthopedic fixation procedures because specialized trauma centers handled complex surgical cases. Sports medicine and reconstructive orthopedic procedures increased by 16% during 2025 across Gulf countries. Minimally invasive orthopedic surgery adoption expanded by 18%, improving recovery periods and reducing hospitalization durations. Europe-manufactured orthopedic staple systems accounted for 43% of premium imports into Middle Eastern healthcare markets. Government healthcare investments improved orthopedic surgical infrastructure by 22%, supporting greater adoption of advanced fixation technologies during 2025.

List of Top Nonabsorbable Bone Staple Companies

• BioMedical Enterprises
• Health-Joy Medical
• Merete
• Neosteo
• Novastep
• Ortho Solutions
• Ortosintese
• Surgival
• Z-Medical
• Zimed Medical
• Zimmer Biomet
• Stryker

List of Top 2 Companies Market Share

• Zimmer Biomet: accounted for approximately 21% of global nonabsorbable bone staple utilization in 2025, supported by extensive orthopedic fixation portfolios and distribution across more than 100 countries.
• Stryker: held nearly 18% share of the nonabsorbable bone staple market during 2025 due to advanced nitinol compression staple systems and robotic-assisted orthopedic surgery integration technologies.

Investment Analysis and Opportunities

Investment activity in the nonabsorbable bone staple market increased significantly during 2025 because orthopedic surgery volumes and minimally invasive fixation procedures expanded globally. Hospitals invested 24% more in robotic-assisted orthopedic surgery systems to improve implant placement precision and reduce surgical complications. Titanium and nitinol manufacturing technologies received substantial investment because shape-memory compression systems improved bone healing efficiency by 27%. Asia-Pacific healthcare modernization projects increased orthopedic surgical infrastructure investment by 24%, creating strong opportunities for advanced fixation implant manufacturers. Outpatient orthopedic surgical centers expanded by 17%, increasing demand for minimally invasive and low-profile staple systems. 3D printing technologies supporting patient-specific orthopedic implants improved customization accuracy by 21%.

Antimicrobial-coated orthopedic staples attracted higher investment because infection reduction rates improved by 14% in trauma surgeries. Pediatric orthopedic procedures represented 19% of total market demand, encouraging manufacturers to develop smaller fixation systems with improved flexibility. Hospitals performing more than 10,000 orthopedic procedures annually increasingly adopted AI-assisted surgical planning software improving fixation precision by 18%. MRI-compatible titanium staples expanded by 22%, creating opportunities for advanced diagnostic-compatible orthopedic fixation products globally.

New Product Development

The nonabsorbable bone staple market experienced rapid innovation during 2025 through shape-memory alloys, robotic-assisted implantation technologies, and advanced orthopedic coatings. Nitinol compression staples improved dynamic fixation performance by 27% while reducing implant migration risks by 16%. Titanium staples with porous bioactive coatings improved osseointegration efficiency by 19% in reconstructive orthopedic procedures. Manufacturers introduced low-profile orthopedic staple systems reducing soft tissue irritation by 18%. Shape-memory fixation devices improved compression consistency during bone fusion procedures, particularly in foot and spinal surgeries. Robotic-assisted orthopedic implantation systems increased staple placement precision by 17% during 2025.

3D-printed patient-specific orthopedic fixation implants expanded by 21%, improving customization for complex deformity corrections. Antimicrobial-coated nonabsorbable staples reduced post-operative infection risks by 14%. MRI-compatible titanium implants represented 63% of newly introduced orthopedic staple systems globally. Pediatric orthopedic staple designs improved flexibility by 15% while minimizing growth plate disruption during reconstructive procedures. Smart surgical planning software integrated with AI-assisted imaging systems improved orthopedic fixation accuracy by 18%. Asia-Pacific manufacturers improved nitinol fatigue resistance by 19%, extending implant durability in high-load orthopedic applications. Bioengineered surface coatings enhancing cellular integration increased by 17% during 2025.

Five Recent Developments

• In 2025, Zimmer Biomet expanded nitinol compression staple systems improving fusion stability by 27% in foot and ankle reconstructive surgeries.
• In 2024, Stryker integrated robotic-assisted orthopedic implantation technologies increasing staple placement precision by 18% during vertebral fixation procedures.
• In 2025, Novastep introduced low-profile titanium staple systems reducing soft tissue irritation by 16% in minimally invasive orthopedic surgeries.
• In 2024, BioMedical Enterprises launched shape-memory nitinol orthopedic staples improving compression performance by 24% during small bone fixation procedures.
• In 2023, Surgival expanded antimicrobial-coated orthopedic fixation systems reducing post-surgical infection risks by 14% in trauma-related orthopedic surgeries.

Report Coverage of Nonabsorbable Bone Staple Market

The nonabsorbable bone staple market report covers orthopedic fixation technologies, surgical procedure trends, material innovations, and regional healthcare adoption patterns across global orthopedic industries. The report evaluates more than 8.7 million orthopedic fixation surgeries worldwide and analyzes utilization trends for titanium, nitinol, and compression staple systems across hospitals and outpatient surgical centers. The study includes segmentation by pediatric and adult orthopedic applications, with adult procedures accounting for 81% of market demand during 2025. Application analysis covers foot surgery, vertebrae surgery, and other orthopedic fixation procedures, with foot surgeries representing 54% of total nonabsorbable bone staple utilization globally.

Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting minimally invasive orthopedic surgery adoption, robotic-assisted implantation technologies, and healthcare modernization initiatives. North America led with 39% of global product demand due to advanced orthopedic surgical infrastructure and high sports injury treatment volumes. The report examines shape-memory nitinol technologies, MRI-compatible titanium implants, antimicrobial coatings, AI-assisted surgical planning systems, and robotic orthopedic implantation technologies. Hospitals represented 71% of global product utilization because advanced surgical centers supported complex fixation procedures. Company profiling includes orthopedic implant manufacturers, robotic surgery technology developers, and advanced fixation system suppliers operating across 2023-2025.